At a 66.7 P/E with a collapsing Forward P/E of 4.7, the market is signaling a violent earnings reset rather than sustainable growth. The headline EPS of 9.4 versus EPS Next Year of $0.17 explains the distortion — this is not growth, it’s normalization after an abnormal spike. The Altman Z-Score of 0.7 is deep distress territory, and a 0.5 current ratio confirms liquidity pressure. Even with a 0.1 Price/Sales suggesting surface-level cheapness, this balance sheet risk prevents the stock from qualifying as true value — it trades more like a leveraged recovery option than a stable GARP opportunity.